Completed
An ad hoc committee will plan and host a 1.5-day public workshop to facilitate discussion focused on the translation of federal investments in biomedical science to innovation in drug development and how the public benefits from that investment in terms of drug pricing and access.
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.
Discover
Events
Convening Activities
Engage
Work with us